PHYSICIAN Dedicated to Discovery … Committed to Care dana-farber

SELECTED
PHYSICIAN PROFILES
Dedicated to Discovery … Committed to Care
www.dana-farber.org
Table of Contents
About Dana-Farber Cancer Institute
Dana-Farber/NHOH
Pediatric Hematologic Malignancies
www.dana-farber.org
3
4
6
2
About Dana-Farber Cancer Institute
For more than 60 years, Dana-Farber Cancer Institute has had one goal: to reduce the suffering
caused by cancer through advanced clinical care and cutting-edge scientific research. As a principal
teaching affiliate of Harvard Medical School, we are able to attract many of the best and brightest
physicians in the world to pursue this mission.
At Dana-Farber, we are committed to a multidisciplinary, compassionate, and collaborative model of care
that truly puts patients and their families at the center of all we do. We work in teams organized around
combating specific types of cancer, and patients have easy and direct access to the full range of specialists
they may need.
Our scientific research is focused on understanding the biology of cancer cells in order to develop more
effective therapies that improve patient outcomes. Our lab scientists and clinicians collaborate closely to
quickly translate findings from the lab into therapies that can be delivered to patients in our clinics.
Dana-Farber is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC), a NCIdesignated Comprehensive Cancer Center. DF/HCC harnesses the expertise and resources of DanaFarber and six other Harvard-affiliated hospitals and research institutions to conduct research focused on
improving the understanding and treatment of cancer. Dana-Farber is also a founding member of the
National Comprehensive Cancer Network, an alliance of the world’s leading cancer centers, working
together to develop cancer treatment guidelines and research that improves the quality and effectiveness
of cancer care. In addition, Dana-Farber has earned “Magnet” status, recognizing the Institute’s highquality patient care, nursing excellence, and innovations in professional nursing practice.
www.dana-farber.org
3
Dana-Farber/NHOH
Dana-Farber/New Hampshire Oncology-Hematology (Dana-Farber/NHOH) provides expert hematology and medical oncology treatment in
Londonderry, NH. Through Dana-Farber/NHOH, patients receive the benefits of Dana-Farber's advances in care and research, while staying close
to home.
In addition, through monthly second-opinion consults, physicians and their patients can discuss diagnoses and treatment plans with Dana-Farber
sub-specialists. The Center also provides an array of specialized and support services to patients and families, including select Dana-Farber clinical
trials, high-risk screening and genetic counseling, nutrition services and survivorship,.
New Patient Appointment Phone: 603-552-9100
Fax: 603-552-9111
Leadership - Dana-Farber/NHOH
Jeanna Walsh, MD, Medical Director
Treatment Team
Hematology/Oncology
Frederick M. Briccetti, MD
Meredith J. Selleck, MD
Jeanna H. Walsh, MD
To make an appointment,
call (603) 552-9100.
www.dana-farber.org/londonderry
4
Dana-Farber/NHOH - Hematology/Oncology
Jeanna H. Walsh, MD
Leadership Title: Medical Director, Dana-Farber/New
Hampshire Oncology-Hematology
Academic Title: Instructor in Medicine, Harvard Medical
School
Discipline: Hematologist/Oncologist
Phone: 603-552-9100
Fax: 603-552-9105
Residency: Strong Memorial Hospital, Internal
Medicine
Fellowship: Strong Memorial Hospital, Hematology
and Oncology
Board Certifications: Hematology
Internal Medicine
Oncology
E-mail: jeanna_walsh@dfci.harvard.edu
Medical School: Upstate Medical University
To make an appointment,
call (603) 552-9100.
www.dana-farber.org/londonderry
5
Pediatric Hematologic Malignancies
The hematologic malignancies team at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is recognized for its expertise in treating
leukemia and lymphoma (including Hodgkin and non-Hodgkin lymphoma), diseases that comprise approximately one-third of all childhood cancer
cases. Our physicians head the Dana-Farber Cancer Institute ALL Consortium, an international organization focused on acute lymphoblastic
leukemia (ALL) treatment and research. Our treatment results for children with newly diagnosed ALL are among the best published cure rates.
New Patient Appointment Phone: 617-632-5508 or 888-733-4662
Fax: 617-582-7434
Email: pedi_onc@dfci.harvard.edu
Leadership - Pediatric Hematologic Malignancies Center
Lewis Silverman, MD, Clinical Director, Hematologic Malignancies Center
Treatment Team
Pathology
Mark D. Fleming, MD, DPhil
Marian Harris, MD
Olga K. Weinberg, MD
Hematology/Oncology
Prasanna Ananth, MD, MPH
Shelly C. Bernstein, MD, PhD
Amy L. Billett, MD
Kira Bona, MD, MPH
Brian D. Crompton, MD
Kimberly J. Davies, MD
Barbara A. Degar, MD
Erica Esrick, MD
Paola M. Friedrich, MD, MPH
Alejandro Gutierrez, MD
Andrew L. Hong, MD
Jennifer C. Kesselheim, MD, M.Ed, MBE
Birgit Knoechel, MD, PhD
Brenton Mar, MD, PhD
Stuart H. Orkin, MD
Barry H. Paw, MD, PhD
Andrew E. Place, MD, PhD
Raffaele Renella, MD, PhD
Stephen E. Sallan, MD
Lewis B. Silverman, MD
Kimberly Stegmaier, MD
Lynda M. Vrooman, MD
Loren D. Walensky, MD, PhD
Joanna S. Yi, MD
Radiation Oncology
Alan D. D'Andrea, MD
Karen J. Marcus, MD
To make an appointment,
please call (888) 733-4662
www.danafarberbostonchildrens.org
6
Pediatric Hematologic Malignancies - Hematology/Oncology
Loren D. Walensky, MD, PhD
Academic Title: Associate Professor of Pediatrics,
Harvard Medical School
Discipline: Pediatric Hematologist/Oncologist
Phone: 617-632-6307
Fax: 617-582-8240
E-mail: loren_walensky@dfci.harvard.edu
Fellowship: Boston Children's Hospital/Dana-Farber
Cancer Institute, Pediatric
Hematology/Oncology
Board Certifications: Pediatrics
Pediatric Hematology/Oncology
Area of Expertise: Hematologic malignancies
Medical School: Johns Hopkins University School of
Medicine
Residency: Boston Combined Residency Program,
Boston Children's Hospital/Boston
Medical Center, Pediatrics
To make an appointment,
please call (888) 733-4662
www.danafarberbostonchildrens.org
7